Prologis Pharmaceutical (000739.SZ) released results for the first three quarters, with net profit of 870 million yuan, an increase of 2.15% over the previous year

According to the Zhitong Finance App, Puluo Pharmaceutical (000739.SZ) released its report for the third quarter of 2024. In the first three quarters, the company achieved operating income of 9.29 billion yuan, an increase of 9.30% over the previous year, achieved net profit attributable to shareholders of listed companies of 870 million yuan, an increase of 2.15% year on year, and achieved net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 831 million yuan, an increase of 0.40% year on year.